These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19124764)

  • 21. Anti-HIV antibody-dependent activation of NK cells impairs NKp46 expression.
    Parsons MS; Tang CC; Jegaskanda S; Center RJ; Brooks AG; Stratov I; Kent SJ
    J Immunol; 2014 Jan; 192(1):308-15. PubMed ID: 24319263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15.
    Loubeau M; Ahmad A; Toma E; Menezes J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):137-45. PubMed ID: 9390564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Early Antibody-Dependent Cell-Mediated Cytotoxicity Response Is Associated With Lower Viral Set Point in Individuals With Primary HIV Infection.
    Chen X; Lin M; Qian S; Zhang Z; Fu Y; Xu J; Han X; Ding H; Dong T; Shang H; Jiang Y
    Front Immunol; 2018; 9():2322. PubMed ID: 30356637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in (51)Cr-release and CD107a assays.
    Mata MM; Mahmood F; Sowell RT; Baum LL
    J Immunol Methods; 2014 Apr; 406():1-9. PubMed ID: 24561308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Slaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibody-dependent activation and cytolysis against allogeneic T cells.
    Gooneratne SL; Richard J; Lee WS; Finzi A; Kent SJ; Parsons MS
    J Virol; 2015 Jan; 89(1):97-109. PubMed ID: 25320293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity.
    Kramski M; Schorcht A; Johnston AP; Lichtfuss GF; Jegaskanda S; De Rose R; Stratov I; Kelleher AD; French MA; Center RJ; Jaworowski A; Kent SJ
    J Immunol Methods; 2012 Oct; 384(1-2):51-61. PubMed ID: 22841577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.
    Lee WS; Prévost J; Richard J; van der Sluis RM; Lewin SR; Pazgier M; Finzi A; Parsons MS; Kent SJ
    J Virol; 2019 May; 93(10):. PubMed ID: 30842324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of NK cells by ADCC responses during early HIV infection.
    Chung AW; Navis M; Isitman G; Centre R; Finlayson R; Bloch M; Gelgor L; Kelleher A; Kent SJ; Stratov I
    Viral Immunol; 2011 Apr; 24(2):171-5. PubMed ID: 21449728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV inhibits early signal transduction events triggered by CD16 cross-linking on NK cells, which are important for antibody-dependent cellular cytotoxicity.
    Lichtfuss GF; Meehan AC; Cheng WJ; Cameron PU; Lewin SR; Crowe SM; Jaworowski A
    J Leukoc Biol; 2011 Jan; 89(1):149-58. PubMed ID: 20884651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells.
    Fischer L; Penack O; Gentilini C; Nogai A; Muessig A; Thiel E; Uharek L
    Exp Hematol; 2006 Jun; 34(6):753-9. PubMed ID: 16728280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of NK cells by HIV-specific ADCC antibodies: role for granulocytes in expressing HIV-1 peptide epitopes.
    Madhavi V; Navis M; Chung AW; Isitman G; Wren LH; De Rose R; Kent SJ; Stratov I
    Hum Vaccin Immunother; 2013 May; 9(5):1011-8. PubMed ID: 23324623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection.
    Wren LH; Chung AW; Isitman G; Kelleher AD; Parsons MS; Amin J; Cooper DA; ; Stratov I; Navis M; Kent SJ
    Immunology; 2013 Feb; 138(2):116-23. PubMed ID: 23173935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWH.
    Tomescu C; Kroll K; Colon K; Papasavvas E; Frank I; Tebas P; Mounzer K; Reeves RK; Montaner LJ
    Eur J Immunol; 2021 Aug; 51(8):2051-2061. PubMed ID: 34086344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
    Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M
    Front Immunol; 2018; 9():244. PubMed ID: 29651286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker.
    Schmohl JU; Felices M; Taras E; Miller JS; Vallera DA
    Mol Ther; 2016 Aug; 24(7):1312-22. PubMed ID: 27157665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
    Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
    J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses.
    Prévost J; Richard J; Medjahed H; Alexander A; Jones J; Kappes JC; Ochsenbauer C; Finzi A
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker.
    Schmohl JU; Felices M; Todhunter D; Taras E; Miller JS; Vallera DA
    Oncotarget; 2016 Nov; 7(45):73830-73844. PubMed ID: 27650544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapy.
    Morrison BJ; Roman JA; Luke TC; Nagabhushana N; Raviprakash K; Williams M; Sun P
    J Virol Methods; 2017 Oct; 248():7-18. PubMed ID: 28624584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC.
    Lisovsky I; Kant S; Tremblay-McLean A; Isitman G; Kiani Z; Dupuy FP; Gilbert L; Bruneau J; Shoukry NH; Lebouché B; Bernard NF
    J Leukoc Biol; 2019 Mar; 105(3):551-563. PubMed ID: 30698860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.